Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis

BACKGROUND AND AIMS: Type 2 diabetes is one of the leading causes of the development and progression of diabetic kidney disease, culminating in end-stage renal disease. Approximately two decades after successful implementation of the renin–angiotensin–aldosterone blocking system, three classes of ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosal, Samit, Sinha, Binayak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943809/
https://www.ncbi.nlm.nih.gov/pubmed/36566447
http://dx.doi.org/10.1007/s13300-022-01359-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943809/
https://www.ncbi.nlm.nih.gov/pubmed/36566447
http://dx.doi.org/10.1007/s13300-022-01359-0

Ejemplares similares